UnitedHealth Group (NYSE:UNH) posted its earnings results on Tuesday. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.60 by $0.13, MarketWatch Earnings reports. The company had revenue of $60.30 billion for the quarter, compared to analyst estimates of $59.72 billion. UnitedHealth Group had a net margin of 5.30% and a return on equity of 24.38%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the business posted $3.04 earnings per share. UnitedHealth Group updated its FY 2019 guidance to $14.50-14.75 EPS and its FY19 guidance to $14.50-14.75 EPS.
Shares of UNH stock opened at $220.96 on Wednesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.64. UnitedHealth Group has a 12-month low of $215.82 and a 12-month high of $287.94. The firm has a market cap of $220.89 billion, a PE ratio of 17.16, a P/E/G ratio of 1.18 and a beta of 0.79.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 1.63%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is 27.95%.
In other news, Director Gail R. Wilensky sold 2,930 shares of the stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $253.39, for a total transaction of $742,432.70. Following the completion of the sale, the director now owns 64,726 shares of the company’s stock, valued at $16,400,921.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction on Thursday, January 17th. The stock was sold at an average price of $260.55, for a total transaction of $3,908,250.00. Following the sale, the director now directly owns 193,872 shares of the company’s stock, valued at approximately $50,513,349.60. The disclosure for this sale can be found here. Insiders have sold 32,930 shares of company stock valued at $8,495,383 in the last three months. 0.87% of the stock is owned by insiders.
Institutional investors have recently added to or reduced their stakes in the stock. CI Investments Inc. lifted its holdings in shares of UnitedHealth Group by 5.8% in the 3rd quarter. CI Investments Inc. now owns 949,719 shares of the healthcare conglomerate’s stock valued at $252,663,000 after purchasing an additional 52,023 shares during the last quarter. Martingale Asset Management L P lifted its holdings in shares of UnitedHealth Group by 1.7% in the 3rd quarter. Martingale Asset Management L P now owns 214,133 shares of the healthcare conglomerate’s stock valued at $56,969,000 after purchasing an additional 3,598 shares during the last quarter. Blue Fin Capital Inc. lifted its holdings in shares of UnitedHealth Group by 7.2% in the 3rd quarter. Blue Fin Capital Inc. now owns 10,689 shares of the healthcare conglomerate’s stock valued at $2,844,000 after purchasing an additional 722 shares during the last quarter. Ally Financial Inc. purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $2,660,000. Finally, Port Capital LLC lifted its holdings in shares of UnitedHealth Group by 2.3% in the 3rd quarter. Port Capital LLC now owns 9,059 shares of the healthcare conglomerate’s stock valued at $2,410,000 after purchasing an additional 202 shares during the last quarter. 86.68% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: This report was originally posted by PressOracle and is owned by of PressOracle. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://pressoracle.com/news/2019/04/17/unitedhealth-group-unh-announces-quarterly-earnings-results.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Blue-Chip Stocks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.